Prediction of MS disability by multimodal evoked potentials: investigation during relapse or in the relapse-free

R Schlaeger1, M D'Souza1, C Schindler2

  • 1Department of Neurology, University Hospital Basel, Switzerland; University of Basel, Switzerland.

Abstract

Insights

Timing of evoked potential (EP) tests in multiple sclerosis (MS) impacts disability prediction. Performing EP investigations during the relapse-free interval, not during a relapse, better predicts medium-term MS disability.

Area of Science:

  • Neuroscience
  • Clinical Neurology
  • Biomedical Engineering

Background:

  • Predicting disability progression in multiple sclerosis (MS) is crucial for patient management.
  • Multimodal evoked potentials (EPs) assess the integrity of sensory and motor pathways.
  • Optimal timing for EP investigations to predict MS disability remains unclear.

Purpose of the Study:

  • To determine if the timing of multimodal EP investigations (during relapse vs. relapse-free interval) influences their predictive value for MS disability.
  • To compare the predictive power of EP measures taken at different time points in relation to MS relapses.

Main Methods:

  • Two groups of MS patients underwent visual, motor, and somatosensory EPs either during a relapse (Group 1) or in remission (Group 2).
  • Expanded Disability Status Scale (EDSS) was assessed at baseline (T0) and 3 years (T2).
  • Linear regression analyzed the association between baseline EP measures (s-EP-Q(T0)) and EDSS(T2) for each group.

Main Results:

  • Group 2 (relapse-free) showed a significant prediction of EDSS(T2) by s-EP-Q(T0) (R²=0.47).
  • Group 1 (during relapse) did not show a significant prediction (R²=0.07).
  • Median EDSS at 3 years was similar between groups, despite different baseline EDSS and EP predictive power.

Conclusions:

  • In early MS, the functional impact of relapses is a better predictor of medium-term disability than EP measures taken during an acute relapse.
  • Multimodal EPs are valuable for predicting MS disability when conducted during the relapse-free interval.